RSV-F vaccine: Completed Phase I enrollment

Novavax completed enrollment of about 150 healthy volunteers ages 18-49 in a double-blind,

Read the full 133 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE